Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Compatibility of Triheptanoin (C7) With the Ketogenic Diet in Patients Diagnosed With Glucose Transporter Type 1 Deficiency

Trial Profile

Compatibility of Triheptanoin (C7) With the Ketogenic Diet in Patients Diagnosed With Glucose Transporter Type 1 Deficiency

Recruiting
Phase of Trial: Phase 0

Latest Information Update: 16 Nov 2018

At a glance

  • Drugs Triheptanoin (Primary)
  • Indications De Vivo disease
  • Focus Therapeutic Use
  • Most Recent Events

    • 01 Nov 2018 Planned End Date changed from 1 Apr 2023 to 5 Jul 2023.
    • 01 Nov 2018 Planned primary completion date changed from 1 Apr 2023 to 5 Jul 2021.
    • 01 Nov 2018 Status changed from not yet recruiting to recruiting.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top